 |
This Week In MedicineAuthor: A.I.O. Language: en-us Genres: Health & Fitness, Medicine Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
NEJM November 5, 2026 Plozasiran for Severe Hypertriglyceridemia and Risk of Pancreatitis
Thursday, 5 November, 2026
Recent clinical research evaluated the effectiveness of plozasiran, an innovative RNA-based therapy, in treating individuals diagnosed with severe hypertriglyceridemia. Across two closely monitored trials involving 757 participants, patients received either the targeted medication or a placebo to measure changes in fasting lipid levels over a one-year period. The findings revealed that administration of the drug resulted in dramatic triglyceride reductions compared to the control group. Furthermore, patients treated with plozasiran experienced a substantially lower incidence of acute pancreatitiswithout an increase in overall adverse events. Ultimately, the investigation demonstrates that this therapeutic approach effectively manages dangerous lipid elevations and significantly mitigates pancreatic health risks.
